LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: PepMLM: Target Sequence-Conditioned Generation of Peptide Binders via Masked Language Modeling.

    Chen, Tianlai / Pertsemlidis, Sarah / Watson, Rio / Kavirayuni, Venkata Srikar / Hsu, Ashley / Vure, Pranay / Pulugurta, Rishab / Vincoff, Sophia / Hong, Lauren / Wang, Tian / Yudistyra, Vivian / Haarer, Elena / Zhao, Lin / Chatterjee, Pranam

    ArXiv

    2023  

    Abstract: Target proteins that lack accessible binding pockets and conformational stability have posed increasing challenges for drug development. Induced proximity strategies, such as PROTACs and molecular glues, have thus gained attention as pharmacological ... ...

    Abstract Target proteins that lack accessible binding pockets and conformational stability have posed increasing challenges for drug development. Induced proximity strategies, such as PROTACs and molecular glues, have thus gained attention as pharmacological alternatives, but still require small molecule docking at binding pockets for targeted protein degradation (TPD). The computational design of protein-based binders presents unique opportunities to access "undruggable" targets, but have often relied on stable 3D structures or predictions for effective binder generation. Recently, we have leveraged the expressive latent spaces of protein language models (pLMs) for the prioritization of peptide binders from sequence alone, which we have then fused to E3 ubiquitin ligase domains, creating a CRISPR-analogous TPD system for target proteins. However, our methods rely on training discriminator models for ranking heuristically or unconditionally-derived "guide" peptides for their target binding capability. In this work, we introduce
    Language English
    Publishing date 2023-11-17
    Publishing country United States
    Document type Preprint
    ISSN 2331-8422
    ISSN (online) 2331-8422
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: PepMLM

    Chen, Tianlai / Pertsemlidis, Sarah / Kavirayuni, Venkata Srikar / Vure, Pranay / Pulugurta, Rishab / Hsu, Ashley / Vincoff, Sophia / Yudistyra, Vivian / Hong, Lauren / Wang, Tian / Haarer, Elena / Zhao, Lin / Chatterjee, Pranam

    Target Sequence-Conditioned Generation of Peptide Binders via Masked Language Modeling

    2023  

    Abstract: Target proteins that lack accessible binding pockets and conformational stability have posed increasing challenges for drug development. Induced proximity strategies, such as PROTACs and molecular glues, have thus gained attention as pharmacological ... ...

    Abstract Target proteins that lack accessible binding pockets and conformational stability have posed increasing challenges for drug development. Induced proximity strategies, such as PROTACs and molecular glues, have thus gained attention as pharmacological alternatives, but still require small molecule docking at binding pockets for targeted protein degradation (TPD). The computational design of protein-based binders presents unique opportunities to access undruggable targets, but have often relied on stable 3D structures or predictions for effective binder generation. Recently, we have leveraged the expressive latent spaces of protein language models (pLMs) for the prioritization of peptide binders from sequence alone, which we have then fused to E3 ubiquitin ligase domains, creating a CRISPR-analogous TPD system for target proteins. However, our methods rely on training discriminator models for ranking heuristically or unconditionally-derived guide peptides for their target binding capability. In this work, we introduce PepMLM, a purely target sequence-conditioned de novo generator of linear peptide binders. By employing a novel masking strategy that uniquely positions cognate peptide sequences at the terminus of target protein sequences, PepMLM tasks the state-of-the-art ESM-2 pLM to fully reconstruct the binder region, achieving low perplexities matching or improving upon previously-validated peptide-protein sequence pairs. After successful in silico benchmarking with AlphaFold-Multimer, we experimentally verify PepMLM's efficacy via fusion of model-derived peptides to E3 ubiquitin ligase domains, demonstrating endogenous degradation of target substrates in cellular models. In total, PepMLM enables the generative design of candidate binders to any target protein, without the requirement of target structure, empowering downstream programmable proteome editing applications.
    Keywords Quantitative Biology - Biomolecules
    Publishing date 2023-10-05
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Engineered Immunogens to Expose Conserved Epitopes Targeted by Broad Coronavirus Antibodies

    Kapingidza, Brenda / Marston, Daniel J / Harris, Caitlin / Wrapp, Daniel / Winters, Kaitlyn / Rhodes, Brianna / Vure, Pranay / Woods, Christopher W / Petzold, Elizabeth A / Walter, Emmanuel B / Parks, Rob / Barr, Maggie / Yin, Qi / Cain, Derek W / Wiehe, Kevin / Saunders, Kevin O / Haynes, Barton F / Azoitei, Mihai L

    bioRxiv

    Abstract: Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which can readily mutate to escape acquired immunity. Other regions in the spike S2 subunit, such as the fusion peptide and the stem helix, are highly ... ...

    Abstract Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which can readily mutate to escape acquired immunity. Other regions in the spike S2 subunit, such as the fusion peptide and the stem helix, are highly conserved across sarbecoviruses and recognized by broadly reactive antibodies, providing hope that targeting these epitopes by vaccination could offer protection against both current and emergent viruses. Here we employed computational modeling to design epitope scaffolds that display the fusion peptide and the stem helix epitopes. The engineered proteins bound both mature and germline versions of multiple broad and protective human antibodies with high affinity. Binding specificity was confirmed both biochemically and via high resolution crystal structures. Finally, the epitope scaffolds showed potent engagement of antibodies and memory B-cells from subjects previously exposed to SARS-CoV2, illustrating their potential to elicit antibodies against the fusion peptide and the stem helix by vaccination.
    Keywords covid19
    Language English
    Publishing date 2023-02-28
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2023.02.27.530277
    Database COVID19

    Kategorien

  4. Article: Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes.

    Kapingidza, Brenda / Marston, Daniel J / Harris, Caitlin / Wrapp, Daniel / Winters, Kaitlyn / Mielke, Dieter / Xiaozhi, Lu / Yin, Qi / Foulger, Andrew / Parks, Rob / Barr, Maggie / Newman, Amanda / Schäfer, Alexandra / Eaton, Amanda / Flores, Justine Mae / Harner, Austin / Cantazaro, Nicholas J / Mallory, Michael L / Mattocks, Melissa D /
    Beverly, Christopher / Rhodes, Brianna / Mansouri, Katayoun / Itallie, Elizabeth Van / Vure, Pranay / Manness, Brooke / Keyes, Taylor / Stanfield-Oakley, Sherry / Woods, Christopher W / Petzold, Elizabeth A / Walter, Emmanuel B / Wiehe, Kevin / Edwards, Robert J / Montefiori, David / Ferrari, Guido / Baric, Ralph / Cain, Derek W / Saunders, Kevin O / Haynes, Barton F / Azoitei, Mihai L

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues ... ...

    Abstract Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues 815-823 adjacent to the fusion peptide, are highly conserved across sarbecoviruses and are recognized by broadly reactive antibodies, providing hope that vaccines targeting these epitopes could offer protection against both current and emergent viruses. Here we employed computational modeling to design scaffolded immunogens that display the spike 815-823 peptide and the stem helix epitopes without the distracting and immunodominant RBD. These engineered proteins bound with high affinity and specificity to the mature and germline versions of previously identified broadly protective human antibodies. Epitope scaffolds interacted with both sera and isolated monoclonal antibodies with broadly reactivity from individuals with pre-existing SARS-CoV-2 immunity. When used as immunogens, epitope scaffolds elicited sera with broad betacoronavirus reactivity and protected as "boosts" against live virus challenge in mice, illustrating their potential as components of a future pancoronavirus vaccine.
    Language English
    Publishing date 2023-09-17
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.02.27.530277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Engineered immunogens to elicit antibodies against conserved coronavirus epitopes.

    Kapingidza, A Brenda / Marston, Daniel J / Harris, Caitlin / Wrapp, Daniel / Winters, Kaitlyn / Mielke, Dieter / Xiaozhi, Lu / Yin, Qi / Foulger, Andrew / Parks, Rob / Barr, Maggie / Newman, Amanda / Schäfer, Alexandra / Eaton, Amanda / Flores, Justine Mae / Harner, Austin / Catanzaro, Nicholas J / Mallory, Michael L / Mattocks, Melissa D /
    Beverly, Christopher / Rhodes, Brianna / Mansouri, Katayoun / Van Itallie, Elizabeth / Vure, Pranay / Dunn, Brooke / Keyes, Taylor / Stanfield-Oakley, Sherry / Woods, Christopher W / Petzold, Elizabeth A / Walter, Emmanuel B / Wiehe, Kevin / Edwards, Robert J / Montefiori, David C / Ferrari, Guido / Baric, Ralph / Cain, Derek W / Saunders, Kevin O / Haynes, Barton F / Azoitei, Mihai L

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 7897

    Abstract: Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues ... ...

    Abstract Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues 815-823 adjacent to the fusion peptide, are highly conserved across sarbecoviruses and are recognized by broadly reactive antibodies, providing hope that vaccines targeting these epitopes could offer protection against both current and emergent viruses. Here we employ computational modeling to design scaffolded immunogens that display the spike 815-823 peptide and the stem helix epitopes without the distracting and immunodominant receptor binding domain. These engineered proteins bind with high affinity and specificity to the mature and germline versions of previously identified broadly protective human antibodies. Epitope scaffolds interact with both sera and isolated monoclonal antibodies with broadly reactivity from individuals with pre-existing SARS-CoV-2 immunity. When used as immunogens, epitope scaffolds elicit sera with broad betacoronavirus reactivity and protect as "boosts" against live virus challenge in mice, illustrating their potential as components of a future pancoronavirus vaccine.
    MeSH term(s) Humans ; Animals ; Mice ; Epitopes ; Antibodies, Viral ; SARS-CoV-2 ; Immunodominant Epitopes ; Peptides ; Spike Glycoprotein, Coronavirus ; Antibodies, Neutralizing
    Chemical Substances Epitopes ; Antibodies, Viral ; Immunodominant Epitopes ; Peptides ; Spike Glycoprotein, Coronavirus ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-11-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-43638-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top